We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

150 hedge funds and large institutions have $345M invested in DIPLOMAT PHARMACY, INC. in 2019 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 51 increasing their positions, 36 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $2.8M | Put options by funds: $1.83M

42% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 36

4% less funds holding

Funds holding: 157150 (-7)

16% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 37

60% less capital invested

Capital invested by funds: $871M → $345M (-$526M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
150
Holders Change
-7
Holders Change %
-4.46%
% of All Funds
3.25%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
31
Increased
51
Reduced
36
Closed
37
Calls
$2.8M
Puts
$1.83M
Net Calls
+$965K
Net Calls Change
-$4.75M

DPLO Hedge Fund Activity: Q1 2019 in Review

150 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q1 2019, worth a combined $345M — down 60% from $871M a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of DPLO and 31 opened new positions — a net loss of 6 holders — while 36 trimmed existing stakes and 51 added.

The largest buyer was Deerfield Management, adding an estimated $48.5M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $115M sold.

  • 150 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q1 2019, down from 157 in Q4 2018.
  • Funds reported $345M of DIPLOMAT PHARMACY, INC. stock for Q1 2019, down 60% quarter-over-quarter.
  • 31 funds opened new DIPLOMAT PHARMACY, INC. positions in Q1 2019 and 37 closed out, a net change of -6 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q1 2019 was Deerfield Management, an estimated $48.5M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q1 2019 was Janus Henderson Group, an estimated $115M sold.

Based on aggregated 13F filings for Q1 2019.